Resveratrol counteracts inflammation in human M1 and M2 macrophages upon challenge with 7-oxo-cholesterol: Potential therapeutic implications in atherosclerosis

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Buttari, Brigitta ^a   Profumo, Elisabetta ^a   Segoni, Luca ^a   D'Arcangelo, Daniela ^b   Rossi, Stefania ^a   Facchiano, Francesco ^a   Saso, Luciano ^c   Businaro, Rita ^c   Iuliano, Luigi ^c   Riganò, Rachele ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGES; MOLECULAR BIOLOGY; RESVERATROL; SET THEORY;

ANTI-INFLAMMATORIES; ATHEROSCLEROTIC PLAQUE; GELATIN ZYMOGRAPHY; IMMUNOMODULATORY; METALLOPROTEINASES; MULTIPLEX IMMUNOASSAYS; POTENTIAL MECHANISM; SIGNALING PATHWAYS;

CHOLESTEROL;

7 OXOCHOLESTEROL; CD14 ANTIGEN; CD16 ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATIN; GELATINASE A; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; OXYSTEROL; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; 7-KETOCHOLESTEROL; CHEMOKINE; CHOLESTEROL DERIVATIVE; CYTOKINE; FC RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; SIGNAL PEPTIDE; STILBENE DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BIOLOGICAL ACTIVITY; CELL VIABILITY; DOWN REGULATION; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOASSAY; INFLAMMATION; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MACROPHAGE M1; MACROPHAGE M2; MONOCYTE; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; ZYMOGRAPHY; ATHEROSCLEROSIS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; METABOLISM; PATHOLOGY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD14; ATHEROSCLEROSIS; CELLS, CULTURED; CHEMOKINES; CYTOKINES; DOWN-REGULATION; ENDOCYTOSIS; HUMANS; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KETOCHOLESTEROLS; MACROPHAGES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MONOCYTES; NF-KAPPA B; RECEPTORS, IGG; STILBENES; UP-REGULATION;

EID: 84901917826     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/257543     Document Type: Article

References (44)

1. Hansson G. K., Hermansson A., The immune system in atherosclerosis. Nature Immunology 2011 12 3 204 212 2-s2.0-79951669207 10.1038/ni.2001
2. Libby P., Ridker P. M., Hansson G. K., Progress and challenges in translating the biology of atherosclerosis. Nature 2011 473 7347 317 325 2-s2.0-79956319051 10.1038/nature10146
3. Gui T., Shimokado A., Sun Y., Akasaka T., Muragaki Y., Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery. Mediators of Inflammation 2012 2012 14 693083 10.1155/2012/693083
4. Vaya J., The association between biomarkers in the blood and carotid plaque composition-focusing on oxidized lipids, oxysterols and plaque status. Biochemical Pharmacology 2013 86 15 18 10.1016/j.bcp.2013.01.025
5. Tavakoli S., Asmis R., Reactive oxygen species and thiol redox signaling in the macrophage biology of atherosclerosis. Antioxidants & Redox Signaling 2012 17 1785 1795
6. Mosser D. M., Edwards J. P., Exploring the full spectrum of macrophage activation. Nature Reviews Immunology 2008 8 12 958 969 2-s2.0-56749174940 10.1038/nri2448
7. Gordon S., Martinez F. O., Alternative activation of macrophages: Mechanism and functions. Immunity 2010 32 5 593 604 2-s2.0-77953268611 10.1016/j.immuni.2010.05.007
8. Helming L., Gordon S., Macrophage fusion induced by IL-4 alternative activation is a multistage process involving multiple target molecules. European Journal of Immunology 2007 37 1 33 42 2-s2.0-33846373694 10.1002/eji.200636788 (Pubitemid 46128784)
9. Martinez F. O., Helming L., Gordon S., Alternative activation of macrophages: an immunologic functional perspective. Annual Review of Immunology 2009 27 451 483 2-s2.0-67650485985 10.1146/annurev.immunol.021908.132532
10. Locati M., Mantovani A., Sica A., Macrophage activation and polarization as an adaptive component of innate immunity. Advances in Immunology 2013 120 163 184 10.1016/B978-0-12-417028-5.00006-5
11. Berthier A., Lemaire-Ewing S., Prunet C., Montange T., Vejux A., Pais De Barros J. P., Monier S., Gambert P., Lizard G., Néel D., 7-Ketocholesterol-induced apoptosis: involvement of several pro-apoptotic but also anti-apoptotic calcium-dependent transduction pathways. The FEBS Journal 2005 272 12 3093 3104 2-s2.0-21344436600 10.1111/j.1742-4658.2005.04723.x (Pubitemid 40904696)
12. Deckert V., Perségol L., Viens L., Lizard G., Athias A., Lallemant C., Gambert P., Lagrost L., Inhibitors of arterial relaxation among components of human oxidized low-density lipoproteins: cholesterol derivatives oxidized in position 7 are potent inhibitors of endothelium-dependent relaxation. Circulation 1997 95 3 723 731 2-s2.0-0031046475 (Pubitemid 27063051)
13. Jessup W., Wilson P., Gaus K., Kritharides L., Oxidized lipoproteins and macrophages. Vascular Pharmacology 2002 38 4 239 248 2-s2.0-0036556749 10.1016/S1537-1891(02)00174-X (Pubitemid 36398269)
14. Larsson H., Böttiger Y., Iuliano L., Diczfalusy U., In vivo interconversion of 7 β -hydroxycholesterol and 7-ketocholesterol, potential surrogate markers for oxidative stress. Free Radical Biology and Medicine 2007 43 5 695 701 2-s2.0-34547118363 10.1016/j.freeradbiomed.2007.04.033 (Pubitemid 47102124)
15. Buttari B., Segoni L., Profumo E., D'arcangelo D., Rossi S., Facchiano F., Businaro R., Iuliano L., Rigano R., 7-Oxo-cholesterol potentiates pro-inflammatory signaling in human M1 and M2 macrophages. Biochemical Pharmacology 2013 86 130 137 10.1016/j.bcp.2013.04.008
16. Clarke J. O., Mullin G. E., A review of complementary and alternative approaches to immunomodulation. Nutrition in Clinical Practice 2008 23 1 49 62 2-s2.0-41149099742 10.1177/011542650802300149 (Pubitemid 351438968)
17. Catalgol B., Batirel S., Taga Y., Ozer N. K., Resveratrol: French paradox revisited. Frontiers in Pharmacology 2012 3 141
18. Buttari B., Profumo E., Capozzi A., Facchiano F., Saso L., Sorice M., Riganò R., Advanced glycation end products of human β 2 glycoprotein I modulate the maturation and function of DCs. Blood 2011 117 23 6152 6161 2-s2.0-79959483052 10.1182/blood-2010-12-325514
19. Buttari B., Profumo E., Facchiano F., Ozturk E. I., Segoni L., Saso L., Rigano R., Resveratrol prevents dendritic cell maturation in response to advanced glycation end products. Oxidative Medicine and Cellular Longevity 2013 2013 12 574029 10.1155/2013/574029
20. Walker J., Schueller K., Schaefer L. M., Pignitter M., Esefelder L., Somoza V., Resveratrol and its metabolites inhibit pro-inflammatory effects of lipopolysaccharides in U-937 macrophages in plasma-representative concentrations. Food & Function 2014 5 74 84
21. Leidi M., Gotti E., Bologna L., Miranda E., Rimoldi M., Sica A., Roncalli M., Palumbo G. A., Introna M., Golay J., M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than M1 cells in vitro. Journal of Immunology 2009 182 7 4415 4422 2-s2.0-64249111614 10.4049/jimmunol.0713732
22. Pu H., Yin J., Wu Y., Zhang D., Wang Y., Zhou R., Jiang L., Liu Y., The association between CD14 gene C-260T polymorphism and coronary heart disease risk: a meta-analysis. Molecular Biology Reports 2013 40 4001 4008 10.1007/s11033-012-2478-y
23. Galkina E., Ley K., Immune and inflammatory mechanisms of atherosclerosis. Annual Review of Immunology 2009 27 165 197 2-s2.0-67650720510 10.1146/annurev.immunol.021908.132620
24. Huang T. T., Lai H. C., Chen Y. B., Chen L. G., Wu Y. H., Ko Y. F., Lu C. C., Chang C. J., Wu C. Y., Martel J., Ojcius D. M., Chong K. Y., Young J. D., cis-Resveratrol produces anti-inflammatory effects by inhibiting canonical and non-canonical inflammasomes in macrophages. Innate Immunity 2013 10.1177/1753425913507096
25. Murray P. J., Wynn T. A., Protective and pathogenic functions of macrophage subsets. Nature Reviews Immunology 2011 11 11 723 737 2-s2.0-80355131976 10.1038/nri3073
26. Peiser L., Gordon S., The function of scavenger receptors expressed by macrophages and their rolein the regulation of inflammation. Microbes and Infection/Institut Pasteur 2001 3 2 149 159 2-s2.0-0035092052 10.1016/S1286-4579(00)01362-9 (Pubitemid 32209332)
27. Porta C., Rimoldi M., Raes G., Brys L., Ghezzi P., Di Liberto D., Dieli F., Ghisletti S., Natoli G., De Baetselier P., Mantovani A., Sica A., Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor B. Proceedings of the National Academy of Sciences of the United States of America 2009 106 35 14978 14983 2-s2.0-70349275277 10.1073/pnas.0809784106
28. Suffee N., Hlawaty H., Meddahi-Pelle A., Maillard L., Louedec L., Haddad O., Martin L., Laguillier C., Richard B., Oudar O., Letourneur D., Charnaux N., Sutton A., RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans. Angiogenesis 2012 15 727 744 10.1007/s10456-012-9285-x
29. Weber C., Noels H., Atherosclerosis: current pathogenesis and therapeutic options. Nature Medicine 2011 17 11 1410 1422 2-s2.0-81255188900 10.1038/nm.2538
30. Capiralla H., Vingtdeux V., Zhao H., Sankowski R., Al-Abed Y., Davies P., Marambaud P., Resveratrol mitigates lipopolysaccharide- and A β -mediated microglial inflammation by inhibiting the TLR4/NF- B/STAT signaling cascade. Journal of Neurochemistry 2012 120 3 461 472 2-s2.0-84855686976 10.1111/j.1471-4159.2011.07594.x
31. Chan C.-C., Cheng L.-Y., Lin C.-L., Huang Y.-H., Lin H.-C., Lee F.-Y., The protective role of natural phytoalexin resveratrol on inflammation, fibrosis and regeneration in cholestatic liver injury. Molecular Nutrition and Food Research 2011 55 12 1841 1849 2-s2.0-82955165813 10.1002/mnfr.201100374
32. Kaneko H., Anzai T., Morisawa M., Kohno T., Nagai T., Anzai A., Takahashi T., Shimoda M., Sasaki A., Maekawa Y., Yoshimura K., Aoki H., Tsubota K., Yoshikawa T., Okada Y., Ogawa S., Fukuda K., Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization. Atherosclerosis 2011 217 2 350 357 2-s2.0-79960698213 10.1016/j.atherosclerosis.2011.03.042
33. Pallares V., Calay D., Cedo L., Castell-Auvi A., Raes M., Pinent M., Ardevol A., Arola L., Blay M., Enhanced anti-inflammatory effect of resveratrol and EPA in treated endotoxin-activated RAW 264.7 macrophages. The British Journal of Nutrition 2012 108 1562 1573 10.1017/S0007114511007057
34. Palmieri D., Pane B., Barisione C., Spinella G., Garibaldi S., Ghigliotti G., Brunelli C., Fulcheri E., Palombo D., Resveratrol counteracts systemic and local inflammation involved in early abdominal aortic aneurysm development. The Journal of Surgical Research 2011 171 2 e237 e246 2-s2.0-81155139677 10.1016/j.jss.2011.07.041
35. Yi C. O., Jeon B. T., Shin H. J., Jeong E. A., Chang K. C., Lee J. E., Lee D. H., Kim H. J., Kang S. S., Cho G. J., Choi W. S., Roh G. S., Resveratrol activates AMPK and suppresses LPS-induced NF-kappaB-dependent COX-2 activation in RAW 264.7 macrophage cells. Anatomy & Cell Biology 2011 44 194 203
36. Zong Y., Sun L., Liu B., Deng Y. S., Zhan D., Chen Y. L., He Y., Liu J., Zhang Z. J., Sun J., Lu D., Resveratrol inhibits LPS-induced MAPKs activation via activation of the phosphatidylinositol 3-kinase pathway in murine RAW 264.7 macrophage cells. PloS ONE 2012 7 e44107
37. Qureshi A. A., Guan X. Q., Reis J. C., Papasian C. J., Jabre S., Morrison D. C., Qureshi N., Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor. Lipids in Health and Disease 2012 11, article 76
38. Hayden M. S., Ghosh S., NF- B in immunobiology. Cell Research 2011 21 2 223 244 2-s2.0-79651473582 10.1038/cr.2011.13
39. Aye I. L. M. H., Waddell B. J., Mark P. J., Keelan J. A., Oxysterols inhibit differentiation and fusion of term primary trophoblasts by activating liver X receptors. Placenta 2011 32 2 183 191 2-s2.0-79951512765 10.1016/j.placenta.2010.12.007
40. Palozza P., Simone R., Catalano A., Boninsegna A., Böhm V., Fröhlich K., Mele M. C., Monego G., Ranelletti F. O., Lycopene prevents 7-ketocholesterol-induced oxidative stress, cell cycle arrest and apoptosis in human macrophages. The Journal of Nutritional Biochemistry 2010 21 1 34 46 2-s2.0-71749099655 10.1016/j.jnutbio.2008.10.002
41. Palozza P., Simone R., Catalano A., Monego G., Barini A., Mele M. C., Parrone N., Trombino S., Picci N., Ranelletti F. O., Lycopene prevention of oxysterol-induced proinflammatory cytokine cascade in human macrophages: inhibition of NF- B nuclear binding and increase in PPAR γ expression. The Journal of Nutritional Biochemistry 2011 22 3 259 268 2-s2.0-79951669719 10.1016/j.jnutbio.2010.02.003
42. Zhong L.-M., Zong Y., Sun L., Guo J.-Z., Zhang W., He Y., Song R., Wang W.-M., Xiao C.-J., Lu D., Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells. PLoS ONE 2012 7 2 2-s2.0-84857395835 10.1371/journal.pone. 0032195 e32195
43. Tome-Carneiro J., Gonzalvez M., Larrosa M., Yanez-Gascon M. J., Garcia-Almagro F. J., Ruiz-Ros J. A., Tomas-Barberan F. A., Garcia-Conesa M. T., Espin J. C., Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective. Annals of the New York Academy of Sciences 2013 1290 37 51 10.1111/nyas.12150
44. Kim M. H., Son Y. J., Lee S. Y., Yang W. S., Yi Y. S., Yoon D. H., Yang Y., Kim S. H., Lee D., Rhee M. H., Kang H., Kim T. W., Sung G. H., Cho J. Y., JAK2-targeted anti-inflammatory effect of a resveratrol derivative 2, 4-dihydroxy-N-(4-hydroxyphenyl)benzamide. Biochemical Pharmacology 2013 86 1747 1761 10.1016/j.bcp.2013.10.006